Real-world outcomes among patients with HER2+ metastatic breast cancer with brain metastases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-world outcomes among patients with HER2+ metastatic breast cancer with brain metastases

Published:2022-06 Issue:6 Volume:28 Page:657-666
ISSN:2376-0540
Container-title:Journal of Managed Care & Specialty Pharmacy
language:en
Short-container-title:JMCP

Author:

DeBusk Kendra¹,Ike Chiemeka¹²,Lindegger Nicolas¹³,Schwartz Naomi¹,Surinach Andy⁴,Liu Yutong⁴,Forero-Torres Andres¹

Affiliation:

1. Seagen Inc., Bothell, WA.

2. EMD Serono Inc.

3. Takeda Pharmaceuticals Inc.

4. Genesis Research, Hoboken, NJ.

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

Reference39 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Cancer statistics, 2020

3. Patterns of breast cancer relapse in accordance to biological subtype

4. Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study

5. Molecular subtype predicts incidence and prognosis of brain metastasis from breast cancer in SEER database

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A real-world study of treatment sequences and second-line clinical outcomes in patients with HER2-positive metastatic breast cancer in US community practice;International Journal of Clinical Oncology;2024-03-25

2. Adeno-associated virus-mediated trastuzumab delivery to the central nervous system for human epidermal growth factor receptor 2+ brain metastasis;Cancer Gene Therapy;2024-03-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP